Abstract
Proposed legislation that would allow anyone to dispense three days of buprenorphine or methadone to patients has been opposed by the American Association for the Treatment of Opioid Dependence (AATOD). Many AATOD members are opioid treatment programs (OTPs), which dispense medications to treat opioid use disorder (OUD) — primarily, methadone, but also buprenorphine and naltrexone. The proposed legislation, H.R. 2281 (the Easy Medication Access and Treatment for Opioid Addiction Act), would require the Drug Enforcement Administration (DEA) to revise regulations to allow a practitioner to administer up to a three‐day supply of opioids to an individual at one time “for purposes of relieving acute withdrawal symptoms while the individual awaits arrangements for narcotic treatment,” according to the bill summary. Current regulations authorize up to a one‐day supply of narcotic drugs for an individual at one time, for a total of up to three days.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
